Did you know that Truthout is a nonprofit and independently funded by readers like you? If you value what we do, please support our work with a donation.

US President Donald Trump on Thursday launched a website, branded with his name, in a purported effort to help patients buy prescription drugs at lower prices.

But experts, watchdog groups, and Democratic lawmakers said TrumpRx will likely do little for consumers — or for the broader goal of bringing down exorbitant medicine costs — while further enriching Big Pharma and potentially lining the pockets of his eldest son, Donald Trump Jr.

TrumpRx.gov, launched in partnership with pharmaceutical giants, points users to direct-to-patient sales platforms hosted by drug companies to facilitate the purchase of an extremely limited selection of medications. For example, TrumpRx’s listing for Farxiga links users to AstraZeneca Direct, where patients can pay out of pocket for the type 2 diabetes medication.

Donald Trump Jr. is on the board of BlinkRx, a prescription drug platform that stands to benefit from the Trump administration’s promotion of direct-to-patient medicine sales. In December, the president’s son reportedly met with top drug company executives and administration officials responsible for regulating the pharmaceutical industry — a gathering hosted by BlinkRx.

Frank Pallone Jr. (D-NJ), the top Democrat on the House Energy and Commerce Committee, said in a statement Thursday that TrumpRx “not only threatens patients’ health, safety, and privacy, but also likely........

© Truthout